Metastatic potential in T1 and T2 colorectal cancer
- PMID: 16334758
Metastatic potential in T1 and T2 colorectal cancer
Abstract
Background/aims: Survival of patients with colorectal cancer confined to the muscularis propria (stage I) is excellent after curative resection. However, some patients are likely to develop lymph node and distant metastasis that can ultimately cause death. The purpose of this study was to identify the possible predictors of lymph node and distant metastasis in T1 and T2 colorectal cancers.
Methodology: In total 208 patients with T1 and T2 colorectal cancers who underwent surgical resection in Taipei Veterans General Hospital from July 1996 to December 2001 were enrolled. The clinicopathological variables including age, gender, tumor location (rectum/colon), preoperative carcinoembryonic antibody level, depth of tumor invasion, lymphovascular invasion, and unfavored histology corresponding to the metastasis assessed pathologically were analyzed. Categorical variables were analyzed using Chi-square with Yates' correction. The independent predictor of lymph node and distant metastasis was determined with multivariate binary logistic regression.
Results: Of the 208 T1 and T2 colorectal cancer patients, 36 (17.3%) had lymph node metastasis and 5 (2.4%) had distant metastasis at surgery. The risk of lymph node metastasis was 14.3% (8/56) in T1 and 18.4% (28/52) in T2 colorectal cancer. The tumors with evidence of lymphovascular invasion had a significantly higher incidence of lymph node metastasis than those without lymphovascular invasion (43.6% vs. 9.4%; p<0.001). The independent risk factor for lymph node metastasis was lymphovascular invasion only (95% confidence interval, 3.37-19.97; p<0.001), whereas that for distant metastasis was preoperative carcinoembryonic antibody level >5ng/mL only (95% confidence interval, 0.03-0.21; p<0.001). The negative predictive value of possible adverse risk factors including preoperative carcinoembryonic antibody level >5ng/mL, lymphovascular invasion, and unfavored differentiation for metastasis was 93.5%.
Conclusions: Considering the negative predictive value of combined possible adverse risk factors, the risk of metastasis still was 6.5%. Therefore radical surgery was recommended for all T1 and T2 stage colorectal cancer patients except if the patient had a very high surgical risk.
Similar articles
-
Can depth of tumour invasion predict lymph node positivity in patients undergoing resection for early rectal cancer? A comparative study between T1 and T2 cancers.Colorectal Dis. 2008 Mar;10(3):231-8. doi: 10.1111/j.1463-1318.2007.01411.x. Colorectal Dis. 2008. PMID: 18257848
-
Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.J Clin Oncol. 2005 Sep 20;23(27):6533-9. doi: 10.1200/JCO.2005.05.516. Epub 2005 Aug 22. J Clin Oncol. 2005. PMID: 16116151
-
The risk of lymph node metastasis in T1 colorectal carcinoma.Hepatogastroenterology. 2004 Jul-Aug;51(58):998-1000. Hepatogastroenterology. 2004. PMID: 15239233
-
Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma.Ann Thorac Surg. 2004 Jul;78(1):238-44. doi: 10.1016/j.athoracsur.2004.02.017. Ann Thorac Surg. 2004. PMID: 15223436 Review.
-
Histopathologic prognostic factors in resected colorectal lung metastases.Ann Thorac Surg. 2005 Jan;79(1):278-82; discussion 283. doi: 10.1016/j.athoracsur.2004.06.096. Ann Thorac Surg. 2005. PMID: 15620957 Review.
Cited by
-
Rectal cancer staging: focus on the prognostic significance of the findings described by high-resolution magnetic resonance imaging.Cancer Imaging. 2013 Jul 22;13(2):277-97. doi: 10.1102/1470-7330.2013.0028. Cancer Imaging. 2013. PMID: 23876415 Free PMC article. Review.
-
T4 Colon Cancer - Current Management.Curr Health Sci J. 2018 Jan-Mar;44(1):5-13. doi: 10.12865/CHSJ.44.01.01. Epub 2018 Jan 5. Curr Health Sci J. 2018. PMID: 30622748 Free PMC article.
-
A novel opportunity in minimally invasive colorectal cancer therapy: defining a role for endoscopic submucosal dissection in the United States.Diagn Ther Endosc. 2013;2013:681783. doi: 10.1155/2013/681783. Epub 2013 Nov 6. Diagn Ther Endosc. 2013. PMID: 24319325 Free PMC article. Review.
-
Rectal cancer confined to the bowel wall: the role of 3 Tesla phased-array MR imaging in T categorization.Br J Radiol. 2018 Feb;91(1082):20170581. doi: 10.1259/bjr.20170581. Epub 2017 Nov 21. Br J Radiol. 2018. PMID: 29120661 Free PMC article.
-
Surgical treatment for rectal cancer: an international perspective on what the medical gastroenterologist needs to know.World J Gastroenterol. 2008 Jun 7;14(21):3281-9. doi: 10.3748/wjg.14.3281. World J Gastroenterol. 2008. PMID: 18528924 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical